ACUTE TREATMENT OF MIGRAINE
Clinical trials for ACUTE TREATMENT OF MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new ACUTE TREATMENT OF MIGRAINE trials appear
Sign up with your email to follow new studies for ACUTE TREATMENT OF MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a second pill stop your migraine? new study investigates
Symptom relief Recruiting nowThis study looks at whether taking a second dose of the migraine medication rimegepant is safe and helpful for adults whose migraine pain isn't fully relieved by the first dose. About 400 people aged 18 and older with a history of migraines will take part. Researchers will track …
Matched conditions: ACUTE TREATMENT OF MIGRAINE
Phase: PHASE4 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jul 02, 2026 01:00 UTC
-
Migraine drug rimegepant tested for safety in kids and teens
Symptom relief Recruiting nowThis study tests the long-term safety of rimegepant, a migraine medication taken as a dissolving tablet, in children and adolescents aged 6 to 18. About 600 participants with a history of migraine will take the drug as needed for up to one year. The main goal is to check for side…
Matched conditions: ACUTE TREATMENT OF MIGRAINE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jul 02, 2026 01:00 UTC
-
New nasal spray could ease Kids' migraines
Symptom relief Recruiting nowThis early-stage study is testing a nasal spray called zavegepant in 16 children aged 6 to 12 who have had migraines for at least 6 months. The main goal is to see if the drug is safe and how the body handles it. Each child gets a single dose based on their weight, and the study …
Matched conditions: ACUTE TREATMENT OF MIGRAINE
Phase: PHASE1 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC